Back

μCas, a novel class of miniature type-V Cas12f nucleases with diverse PAM

Sharrar, A.; Arake de Tacca, L.; Collingwood, T.; Meacham, Z.; Rabuka, D.; Staples-Ager, J.; Schelle, M.

2023-02-16 biochemistry
10.1101/2023.02.03.527072 bioRxiv
Show abstract

Small CRISPR-Cas effectors are key to developing gene editing therapies due to the packaging constraints in viral vectors. While Cas9 and Cas12a CRISPR-Cas effectors have advanced into select clinical applications, their size is prohibitive for efficient delivery of both nuclease and guide RNA in a single viral vector. Type-V Cas12f effectors present a solution given their small size. Here we describe Cas, a novel class of miniature (<490AA) type-V Cas12f nucleases that cleave double stranded DNA in human cells. We determined their optimal trans-activating RNA (tracrRNA) empirically through rational modifications which resulted in an optimal single guide RNA (sgRNA). We show that the Cas nucleases have broader PAM preferences than previously known Cas12f effectors. The unique characteristics of these novel nucleases add to the diversity of the miniature CRISPR-Cas toolbox while the expanded PAM allows for the editing of genomic locations that could not be accessed with existing Cas12f nucleases.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
The CRISPR Journal
○ 39 papers in training set
Top 0.1%
27.0%
Similar papers in this journal
2
ACS Chemical Biology
● 167 papers in training set
Top 0.2%
10.8%
Similar papers in this journal
3
Nucleic Acids Research
◐ 1281 papers in training set
Top 2%
9.8%
Similar papers in this journal
4
Nature Communications
○ 5641 papers in training set
Top 20%
8.0%
Similar papers in this journal
50% of probability mass above
5
Molecular Therapy - Nucleic Acids
○ 25 papers in training set
Top 0.1%
6.4%
Similar papers in this journal
6
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 19%
2.7%
7
Journal of Biological Chemistry
○ 690 papers in training set
Top 4%
2.4%
8
Scientific Reports
○ 3612 papers in training set
Top 41%
2.4%
9
Journal of the American Chemical Society
● 217 papers in training set
Top 1%
2.2%
10
Angewandte Chemie International Edition
○ 93 papers in training set
Top 0.8%
1.9%
11
Molecular Therapy Nucleic Acids
○ 39 papers in training set
Top 0.4%
1.8%
12
iScience
○ 1154 papers in training set
Top 20%
1.5%
13
Biochemistry
● 148 papers in training set
Top 2%
1.5%
14
ACS Synthetic Biology
● 287 papers in training set
Top 2%
1.4%
15
Journal of Molecular Biology
○ 232 papers in training set
Top 3%
1.1%
16
eLife
● 5828 papers in training set
Top 61%
1.1%
17
Molecular Therapy - Methods & Clinical Development
○ 38 papers in training set
Top 0.6%
0.9%
18
Cell Reports
○ 1498 papers in training set
Top 26%
0.9%
19
Molecular Cell
○ 350 papers in training set
Top 5%
0.6%
20
RNA
● 189 papers in training set
Top 1%
0.6%
21
PLOS ONE
● 5266 papers in training set
Top 61%
0.6%
22
ACS Bio & Med Chem Au
● 11 papers in training set
Top 0.1%
0.6%
23
Cell
○ 431 papers in training set
Top 11%
0.6%
24
Molecular Therapy
○ 81 papers in training set
Top 2%
0.6%
25
Communications Biology
○ 993 papers in training set
Top 33%
0.6%
26
Nature Biotechnology
○ 172 papers in training set
Top 5%
0.6%
27
Cell Chemical Biology
○ 94 papers in training set
Top 2%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.